Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.8 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.8 |